Tenax Therapeutics Stock Filter Stocks by Fundamentals
| TENX Stock | USD 3.68 0.09 2.51% |
Tenax Therapeutics fundamentals help investors to digest information that contributes to Tenax Therapeutics' financial success or failures. It also enables traders to predict the movement of Tenax Stock. The fundamental analysis module provides a way to measure Tenax Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tenax Therapeutics stock.
Tenax | Shares Owned by Institutions |
Tenax Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Tenax Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Tenax Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Tenax Therapeutics' value.| Shares | Millennium Management Llc | 2023-09-30 | 0.0 | Lido Advisors, Llc | 2023-12-31 | 0.0 | Lpl Financial Corp | 2023-12-31 | 0.0 | Honkamp Krueger Financial Services Inc | 2023-12-31 | 0.0 | Virtu Financial Llc | 2023-12-31 | 0.0 | Two Sigma Securities, Llc | 2023-12-31 | 0.0 | Hrt Financial Llc | 2023-09-30 | 0.0 | Ci Private Wealth Llc | 2023-09-30 | 191.5 K | Geode Capital Management, Llc | 2023-09-30 | 119 K | State Street Corporation | 2023-09-30 | 95.1 K | Blackrock Inc | 2023-09-30 | 23.9 K |
Tenax Fundamentals
| Return On Equity | -1.61 | ||||
| Return On Asset | -0.68 | ||||
| Current Valuation | (2.22 M) | ||||
| Shares Outstanding | 1.96 M | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 4.07 % | ||||
| Number Of Shares Shorted | 48.99 K | ||||
| Price To Earning | (0.35) X | ||||
| Price To Book | 0.91 X | ||||
| EBITDA | (8.23 M) | ||||
| Net Income | (7.71 M) | ||||
| Cash And Equivalents | 7.23 M | ||||
| Cash Per Share | 0.29 X | ||||
| Total Debt | 500.9 K | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 5.60 X | ||||
| Book Value Per Share | 27.15 X | ||||
| Cash Flow From Operations | (5.9 M) | ||||
| Short Ratio | 0.32 X | ||||
| Earnings Per Share | (31.04) X | ||||
| Target Price | 32.5 | ||||
| Beta | 2.27 | ||||
| Market Capitalization | 7.07 M | ||||
| Total Asset | 11.68 M | ||||
| Retained Earnings | (297.25 M) | ||||
| Working Capital | 8.1 M | ||||
| Current Asset | 21.86 M | ||||
| Current Liabilities | 3.56 M | ||||
| Net Asset | 11.68 M |
About Tenax Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tenax Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tenax Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tenax Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Tenax Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Tenax Therapeutics' short interest history, or implied volatility extrapolated from Tenax Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether Tenax Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tenax Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tenax Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tenax Therapeutics Stock:Check out Tenax Therapeutics Piotroski F Score and Tenax Therapeutics Altman Z Score analysis. For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Tenax Stock analysis
When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Tenax Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tenax Therapeutics. If investors know Tenax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tenax Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (31.04) | Return On Assets (0.68) | Return On Equity (1.61) |
The market value of Tenax Therapeutics is measured differently than its book value, which is the value of Tenax that is recorded on the company's balance sheet. Investors also form their own opinion of Tenax Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Tenax Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tenax Therapeutics' market value can be influenced by many factors that don't directly affect Tenax Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tenax Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tenax Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tenax Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.